Abstract
ABSTRACTObjectivesTo quantify the contributions of polygenic scores, primary care records (presenting symptoms, medical history and common blood tests) and lifestyle factors, for short-term risk prediction of colorectal cancer (CRC) in both all and symptomatic individuals.DesignProspective cohort study.SettingUK Biobank with follow-up until 2018.ParticipantsAll participants with linked primary care records (n=160,526), and a subcohort of participants with a presentation of a symptom associated with CRC (n=50,728).Main outcome measuresOutcome was the first recorded CRC diagnosis within two years. Dynamic risk models with time-varying predictors were derived in a super-landmark framework. Contributions to model discrimination were quantified using novel inclusion-order-agnostic Shapley values of Harrel’s C-index using cross-validation.ResultsC-indices [95% CIs] were 0.74 [0.72-0.75] and 0.71 [0.67-0.77] for the models derived in all and symptomatic participants respectively. The Shapley contributions to model discrimination differed between the two groups of participants for different predictors: 31% (32% in the symptomatic participants) for core predictors (e.g., age, sex, smoking), 16% (12%) for polygenic scores, 27% (30%) for primary care blood tests, 14% (14%) for primary care medical history, 8% (0.5%) for additional lifestyle factors and 4% (12%) for symptoms.ConclusionsPolygenic scores contribute substantially to short-term risk prediction for CRC in both general and symptomatic populations; however, the contribution of information in primary care records (including presenting symptoms, medical history and common blood tests) is greater. There is, however, only a small contribution by the additional lifestyle risk factors which are not routinely collected in primary care.
Publisher
Cold Spring Harbor Laboratory
Reference45 articles.
1. Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer;Ann Oncol,2019
2. NHS digital. Cancer Survival in England, cancers diagnosed 2016 to 2020, followed up to 2021 [Internet]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/cancer-survival-in-england/cancers-diagnosed-2016-to-2020-followed-up-to-2021
3. Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms?;A longitudinal data-linkage study in England. Br J Cancer,2016
4. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests
5. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme